Apex Medical Partners with SLK Vertriebs GmbH and SLK Medical
Taipei, Taiwan – APEX Medical Corp. (TWSE listed Company, ref code 4106) is pleased to announce the acquisition of fifty percent shares of SLK Vertriebs GmbH and SLK Medical GmbH, leading manufacturers and service providers in Pressure Area Care throughout Germany and Europe.
SLK is established by a group of health care professionals that has a particular focus on the patients and their needs. SLK offers medical solutions which are both economically and therapeutically viable. The products range comprises anti-decubitus bedding systems, Intermittent Pneumatic Compression (IPC), bariatric care, decontamination and repair service. In many countries SLK is represented by distributors.
Apex Medical has established its global service network in Europe (Spain, UK, and France), USA, Greater China, and Pan Asia (India and Thailand). The partnership will extend Apex Medical’s footprint into Germany and expand Apex Medical’s growing presence in Europe.
The cooperation will enhance product portfolio and capacity for both parties in Pressure Area Care and Wound Management, and also provide opportunities for Apex Medical’s global service network and SLK’s business growth.
SLK Vertriebs GmbH and SLK Medical GmbH will keep its current operation unchanged, and the companies will be jointly managed by both SLK and Apex Medical management team.About APEX
APEX Medical is a leading manufacturer of its own brand of Wound Management and Respiratory Therapy products and distributes through an established network of international subsidiaries and partners in Europe, the United States, Asia and other international markets. APEX specializes in product development, engineering and marketing products with a dedicated and innovative team of industry professionals. APEX aims to be a global leader in the provision of high quality healthcare products, delivering tested, trialed and clinically evaluated devices while ensuring that its own technology and intellectual property meet the demands of the Wound Management and Respiratory Therapy market./